ÃÊÀ½ÆÄ·Î Áø´ÜµÈ ºñ¾ËÄÚ¿Ã Áö¹æ°£ ȯÀÚ¿¡¼­ Cytokeratin-18°ú ´ë»ç ÁöÇ¥¿ÍÀÇ »ó°ü°ü°è
Clinical Correlation between Serum Cytokeratin-18 and Metabolic Parameters in Patients with Sonographic Non-alcoholic Fatty Liver Disease

´ëÇѼÒÈ­±âÇÐȸÁö 2014³â 64±Ç 4È£ p.206 ~ p.212

°ûµ¿½Å(Kwak Dong-Shin) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
Àü´ë¿ø(Jun Dae-Won) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
Á¶¿µ±Õ(Cho Young-Kyun) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °­ºÏ»ï¼ºº´¿ø ³»°úÇб³½Ç
À̽¹Î(Lee Seung-Min) - ¼º½Å¿©ÀÚ´ëÇб³ ½Äǰ¿µ¾çÇаú
À̼¼È¯(Lee Sae-Hwan) - ¼øÃµÇâ´ëÇб³ Àǰú´ëÇРõ¾Èº´¿ø ³»°úÇб³½Ç
Á¤Àμ·(Jung In-Sub) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
À̼º¿ø(Lee Sung-Won) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
ÀÌÁ¤ÈÆ(Lee Jung-Hoon) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
ÀÌÀº¿µ(Lee Eun-Young) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
³ë¹Î(Rho Min) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
À̰­·Ï(Lee Kang-Lok) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
°íÁرÇ(Ko Jun-Kwon) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
¹Ú¼øÀÀ(Park Soon-Eung) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç

Abstract

Background/Aims: The serum cytokeratin-18 (CK-18) has been suggested to be a surrogate marker of non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the correlation between CK-18 and metabolic parameter in NAFLD patients. Correlation between CK-18 and macronutrient composition was also assessed.

Methods: A total of 212 subjects were recruited. Blood chemistry including fasting glucose, cholesterol level, AST, ALT, and CK-18 were compared. Data on calorie intake and carbohydrate consumption were acquired by five-day-diet diary using 24 hour recall method.

Results: Plasma CK-18 were markedly increased in patient with NAFLD compared with control group (420.4¡¾282.3 vs. 313.6¡¾179,p£¼0.001). Plasma CK-18 were positively correlated with systolic blood pressure (r=0.130), ALT (r=0.503) and negatively correlated with HDL cholesterol (r=?0.246). NAFLD patients with metabolic syndrome had higher CK-18 level than those without metabolic syndrome (484.0 vs. 372.1 U/L, p=0.021). When NAFLD patients were subdivided into two groups with CK-18 cut-off value of 400 U/L, patients with CK-18 level over 400 U/L showed higher body mass index (28.0¡¾4.5 vs. 25.5¡¾4.3), subcutaneous abdominal fat (283.5¡¾172.2 vs. 195.7¡¾147.8), AST (52.7¡¾26.3 vs. 40.7¡¾23.5) and ALT (102.0¡¾52.6 vs. 61.2¡¾32.2). Calorie intake (r=0.301) and carbohydrate intake (r=0.305) also showed positive correlation with CK-18.

Conclusions: Plasma CK-18 showed positive correlation with metabolic parameters as well as calorie and carbohydrate intake when its cut-off value of greater than 400 U/L was used.

Ű¿öµå

Non-alcoholic fatty liver disease, Keratin-18, Metabolic syndrome, Carbohydrates
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå